Kalaris Therapeutics, Inc. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

Kalaris Therapeutics, Inc. (KLRS) — Frequently Asked Questions

Kalaris Therapeutics, Inc. (KLRS) is a publicly traded US company. Explore KLRS's stock price, financial statements, earnings history, margins and key ratios below.

What is the KLRS stock price?

KLRS trades at $4.24 (+1.80% on the day).